Xenon Pharmaceuticals Inc. (XENE)
USD 27.89
(-5.15%)
USD 27.89
(-5.15%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -167.51 Million USD | -73.89% |
| 2022 | -96.33 Million USD | -68.93% |
| 2021 | -57.02 Million USD | -210.65% |
| 2020 | -18.35 Million USD | 42.66% |
| 2019 | -32.01 Million USD | -433.6% |
| 2018 | -6 Million USD | 76.25% |
| 2017 | -25.26 Million USD | -3766.47% |
| 2016 | 689 Thousand USD | -94.62% |
| 2015 | 12.81 Million USD | -42.96% |
| 2014 | 22.46 Million USD | 6.25% |
| 2013 | 21.14 Million USD | 202.6% |
| 2012 | 6.98 Million USD | 1.01% |
| 2011 | 6.91 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -599 Thousand USD | -113.23% |
| 2024 Q2 | -659 Thousand USD | -10.02% |
| 2023 Q4 | 4.52 Million USD | 361.19% |
| 2023 Q2 | -602 Thousand USD | -70.06% |
| 2023 Q1 | -354 Thousand USD | 30.07% |
| 2023 Q3 | -1.73 Million USD | -188.04% |
| 2023 FY | -3.54 Million USD | 96.32% |
| 2022 Q3 | -29.29 Million USD | -35.58% |
| 2022 FY | -96.33 Million USD | -68.93% |
| 2022 Q1 | -10.59 Million USD | 41.63% |
| 2022 Q2 | -21.61 Million USD | -103.98% |
| 2022 Q4 | -506.23 Thousand USD | 98.27% |
| 2021 Q4 | -18.15 Million USD | -68.57% |
| 2021 Q1 | -11.95 Million USD | -21.73% |
| 2021 Q2 | -16.15 Million USD | -35.22% |
| 2021 Q3 | -10.76 Million USD | 33.37% |
| 2021 FY | -57.02 Million USD | -210.65% |
| 2020 FY | -18.35 Million USD | 42.66% |
| 2020 Q2 | 2.66 Million USD | 156.52% |
| 2020 Q1 | -4.71 Million USD | 44.05% |
| 2020 Q3 | -6.49 Million USD | -343.66% |
| 2020 Q4 | -9.81 Million USD | -51.24% |
| 2019 FY | -32.01 Million USD | -433.6% |
| 2019 Q4 | -8.42 Million USD | -34.75% |
| 2019 Q3 | -6.25 Million USD | 23.81% |
| 2019 Q2 | -8.2 Million USD | 10.2% |
| 2019 Q1 | -9.13 Million USD | -2172.89% |
| 2018 FY | -6 Million USD | 76.25% |
| 2018 Q4 | -402 Thousand USD | 93.3% |
| 2018 Q3 | -6 Million USD | -10.78% |
| 2018 Q1 | -5.56 Million USD | 12.74% |
| 2018 Q2 | -5.41 Million USD | 2.73% |
| 2017 Q4 | -6.38 Million USD | 7.52% |
| 2017 Q2 | -6.09 Million USD | -3.52% |
| 2017 FY | -25.26 Million USD | -3766.47% |
| 2017 Q1 | -5.88 Million USD | -1699.73% |
| 2017 Q3 | -6.9 Million USD | -13.23% |
| 2016 Q2 | 71 Thousand USD | -77.24% |
| 2016 Q1 | 312 Thousand USD | -88.27% |
| 2016 FY | 689 Thousand USD | -94.62% |
| 2016 Q4 | 368 Thousand USD | 571.79% |
| 2016 Q3 | -78 Thousand USD | -209.86% |
| 2015 Q2 | 3.33 Million USD | 6.04% |
| 2015 Q4 | 2.65 Million USD | -27.59% |
| 2015 Q3 | 3.67 Million USD | 10.04% |
| 2015 Q1 | 3.14 Million USD | -18.05% |
| 2015 FY | 12.81 Million USD | -42.96% |
| 2014 Q1 | 3.52 Million USD | -6.67% |
| 2014 Q4 | 3.84 Million USD | -66.41% |
| 2014 FY | 22.46 Million USD | 6.25% |
| 2014 Q3 | 11.43 Million USD | 211.61% |
| 2014 Q2 | 3.66 Million USD | 4.09% |
| 2013 FY | 21.14 Million USD | 202.6% |
| 2013 Q1 | 4.02 Million USD | 312.28% |
| 2013 Q2 | 4.02 Million USD | 0.0% |
| 2013 Q3 | 9.31 Million USD | 131.21% |
| 2013 Q4 | 3.77 Million USD | -59.44% |
| 2012 Q3 | 977 Thousand USD | 0.0% |
| 2012 Q4 | 977 Thousand USD | 0.0% |
| 2012 FY | 6.98 Million USD | 1.01% |
| 2011 FY | 6.91 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | 540.531% |
| Alkermes plc | 1.37 Billion USD | 112.186% |
| Agenus Inc. | 139.61 Million USD | 219.981% |
| Aptorum Group Limited | -1.11 Million USD | -14927.703% |
| Ardelyx, Inc. | 106.66 Million USD | 257.051% |
| Dyadic International, Inc. | 922.95 Thousand USD | 18249.491% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 895.366% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -95707.096% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -1154.034% |
| Novavax, Inc. | 639.93 Million USD | 126.176% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -257.634% |
| Pyxis Oncology, Inc. | -2 Million USD | -8275.6% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -32316.7% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 979.651% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -378989.346% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -31685.958% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | -70.553% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 20986.783% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -204182.927% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 223.836% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 2228.218% |
| C4 Therapeutics, Inc. | -96.95 Million USD | -72.782% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 111.036% |
| AlloVir, Inc. | -398 Thousand USD | -41988.442% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 169.584% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 39607.547% |
| Bicycle Therapeutics plc | -129.52 Million USD | -29.333% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 139693.333% |
| ChromaDex Corporation | 50.78 Million USD | 429.878% |
| Chimerix, Inc. | 324 Thousand USD | 51801.235% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -437.455% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -115.872% |
| CRISPR Therapeutics AG | 240.95 Million USD | 169.52% |
| Precision BioSciences, Inc. | 40.47 Million USD | 513.896% |
| Fate Therapeutics, Inc. | -98.16 Million USD | -70.647% |
| Fortress Biotech, Inc. | 57.85 Million USD | 389.548% |
| Fortress Biotech, Inc. | 57.85 Million USD | 389.548% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 1110.509% |
| ImmuCell Corporation | 4.39 Million USD | 3910.309% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | -57.847% |
| Immix Biopharma, Inc. | -5468.00 USD | -3063396.708% |
| Incyte Corporation | 3.44 Billion USD | 104.869% |
| Innoviva, Inc. | 261.06 Million USD | 164.165% |
| IO Biotech, Inc. | -756 Thousand USD | -22057.672% |
| Jaguar Health, Inc. | 7.72 Million USD | 2268.721% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -25127.711% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 239.881% |
| ContextLogic Inc. | 59 Million USD | 383.919% |
| MiMedx Group, Inc. | 266.84 Million USD | 162.775% |
| MEI Pharma, Inc. | 49.32 Million USD | 439.595% |
| NextCure, Inc. | -3.68 Million USD | -4447.014% |
| Onconetix, Inc. | -1.12 Million USD | -14761.356% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -478.266% |
| Opthea Limited | 21.72 Thousand USD | 771333.886% |
| Psyence Biomedical Ltd. | -240.00 USD | -69796566.667% |
| Vaxcyte, Inc. | -75 Million USD | -123.349% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -292109.469% |
| Precigen, Inc. | 106 Thousand USD | 158130.189% |
| Pharming Group N.V. | 220.1 Million USD | 176.106% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 32626.602% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 16701.784% |
| PureTech Health plc | -1.6 Million USD | -10349.906% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 252.6% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 7.66% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -269.58% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -661.868% |
| Acelyrin, Inc. | -115 Thousand USD | -145562.609% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -1666520.237% |
| Summit Therapeutics Inc. | -2.05 Million USD | -8071.317% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -29236.602% |
| Senti Biosciences, Inc. | -2.68 Million USD | -6143.459% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 4235.078% |
| Elevation Oncology, Inc. | -39 Thousand USD | -429417.949% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -3391.288% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -4149.365% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 675.07% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 33872.581% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -304467.273% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 260.916% |
| Seer, Inc. | 7.02 Million USD | 2483.834% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 3926.222% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 877.498% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -141271.075% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -116795.207% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 27606.076% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 239.044% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 153.404% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -3350140.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 6607.848% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -330037.958% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 670.021% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -72103.448% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -33947.154% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -2259.989% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -35199.497% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -1610592.308% |
| Soligenix, Inc. | 97.31 Thousand USD | 172240.868% |
| Century Therapeutics, Inc. | -10.8 Million USD | -1449.746% |
| Kura Oncology, Inc. | -849 Thousand USD | -19630.506% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -149.63% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -113853.741% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 269.137% |
| Autolus Therapeutics plc | -4.86 Million USD | -3341.792% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 504.755% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -99609.524% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 276.844% |
| GRI Bio, Inc. | 10.84 Million USD | 1645.171% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 6694.997% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -1828.307% |
| IGM Biosciences, Inc. | -211.66 Million USD | 20.858% |
| INmune Bio, Inc. | 155 Thousand USD | 108172.258% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 370.447% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -11020.826% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -25732.519% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -572121.084% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 41769.652% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -8292.385% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -53418.211% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 277.335% |
| Verastem, Inc. | -62 Thousand USD | -270080.645% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 6979.343% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -64080.843% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 5633.928% |
| Histogen Inc. | 3.76 Million USD | 4544.468% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 29172.91% |
| Surrozen, Inc. | -27.23 Million USD | -515.174% |
| Organovo Holdings, Inc. | -5.38 Million USD | -3008.406% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -13802.795% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -553.145% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 935.388% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -8460102.02% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 2861.298% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -249430.023% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 208.218% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 114991.632% |
| Apollomics, Inc. | 127 Thousand USD | 131999.213% |
| Amarin Corporation plc | 165.54 Million USD | 201.191% |
| Mesoblast Limited | -9.81 Million USD | -1606.694% |
| Turnstone Biologics Corp. | 16.5 Million USD | 1114.855% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | -51.61% |
| Synaptogenix, Inc. | -6347.00 USD | -2639131.133% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -328354.902% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 203.809% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 109.53% |
| Better Therapeutics, Inc. | -2.72 Million USD | -6038.219% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | -49.35% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 149.548% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -1468273.072% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -2575.911% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -15018.412% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 2389.04% |
| Insmed Incorporated | 239.63 Million USD | 169.903% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 4781.722% |
| OmniAb, Inc. | 14.66 Million USD | 1242.101% |
| Alector, Inc. | -95.05 Million USD | -76.23% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 233.347% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -285.413% |
| Zai Lab Limited | 170.9 Million USD | 198.016% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 304.59% |
| Aura Biosciences, Inc. | -1.29 Million USD | -12835.29% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 128955.385% |
| Immunic, Inc. | -111 Thousand USD | -150811.712% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 1156.591% |
| Veracyte, Inc. | 248.14 Million USD | 167.505% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 97.603% |
| FibroGen, Inc. | 128.9 Million USD | 229.951% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -29700609.22% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -1335.79% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 104.929% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 43162.211% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 147.141% |
| TG Therapeutics, Inc. | 219.1 Million USD | 176.452% |
| Galecto, Inc. | -830 Thousand USD | -20082.169% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -11994.729% |
| Fortrea Holdings Inc. | 424 Million USD | 139.508% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | -94.404% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -29443.563% |
| XBiotech Inc. | -1.74 Million USD | -9505.046% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -15018.412% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -260.466% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -121.77% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 328.209% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 1096.917% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 143.058% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -237.406% |
| Vaxxinity, Inc. | -2.23 Million USD | -7398.299% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 151.266% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -1379.286% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 785.093% |
| NexImmune, Inc. | -1.02 Million USD | -16243.081% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 3102174.074% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -2257.446% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 101.482% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -250565.15% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -4617.319% |
| Ainos, Inc. | -253.73 Thousand USD | -65919.004% |
| Pluri Inc. | 322 Thousand USD | 52122.36% |
| Prothena Corporation plc | -129.2 Million USD | -29.652% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 432.207% |
| Celularity Inc. | 6.75 Million USD | 2579.822% |
| Rallybio Corporation | -150 Thousand USD | -111574.667% |
| Cue Biopharma, Inc. | -32.6 Million USD | -413.73% |
| MeiraGTx Holdings plc | 287 Thousand USD | 58466.551% |
| Omeros Corporation | -69.77 Million USD | -140.061% |
| Humacyte, Inc. | -76.55 Million USD | -118.827% |
| Immunocore Holdings plc | 248.39 Million USD | 167.439% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -1004.305% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 368.526% |
| Blueprint Medicines Corporation | 236.58 Million USD | 170.804% |
| CalciMedica, Inc. | -58 Thousand USD | -288713.793% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -11646.985% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 676.534% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -5790.014% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -442.725% |
| Pulmatrix, Inc. | -8.22 Million USD | -1937.859% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -14217.265% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -41882.957% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 57.995% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 6135.196% |
| Cytokinetics, Incorporated | -322.59 Million USD | 48.073% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 19530.58% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -49023.754% |
| Vor Biopharma Inc. | -3.49 Million USD | -4697.022% |
| Roivant Sciences Ltd. | 109.23 Million USD | 253.35% |
| Evogene Ltd. | 1.39 Million USD | 12073.695% |
| ProKidney Corp. | -3.16 Million USD | -5185.958% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -281.472% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 2542.934% |
| CorMedix Inc. | -205.56 Thousand USD | -81389.77% |
| BioLineRx Ltd. | 1.1 Million USD | 15218.412% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -112.927% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -507512.121% |
| Atai Life Sciences N.V. | -5000.00 USD | -3350140.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -137363.79% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -174391.667% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -11959.899% |
| Sagimet Biosciences Inc. | 2 Million USD | 8475.6% |
| MediciNova, Inc. | 979.7 Thousand USD | 17198.208% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | -98.665% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -177058.268% |
| GeoVax Labs, Inc. | -20.72 Million USD | -708.426% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 168.502% |
| Biomea Fusion, Inc. | -4.2 Million USD | -3887.432% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 119.203% |
| Mereo BioPharma Group plc | 7.42 Million USD | 2355.75% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -53936.129% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -1395833.333% |
| Absci Corporation | -41.84 Million USD | -300.277% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -3350140.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -119.334% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -6706.664% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 178.374% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -17701.488% |
| Allakos Inc. | -6.14 Million USD | -2627.764% |
| Imunon, Inc. | -720 Thousand USD | -23165.394% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -142.785% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 135.199% |
| BioAtla, Inc. | -103.73 Million USD | -61.487% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -1468273.072% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -94007.865% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 31.014% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -53762.379% |
| XOMA Corporation | 3.86 Million USD | 4438.565% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -139.013% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 1232.297% |
| aTyr Pharma, Inc. | -2.38 Million USD | -6914.74% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 1444.398% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -577527.586% |
| Viridian Therapeutics, Inc. | -1 Million USD | -16518.254% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 1288553946.154% |
| Akari Therapeutics, Plc | -4000.00 USD | -4187700.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 126.301% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 86132.418% |
| UroGen Pharma Ltd. | 73.35 Million USD | 328.367% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -527.527% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 1442925.151% |
| Orgenesis Inc. | -5.72 Million USD | -2825.974% |
| Entera Bio Ltd. | -56 Thousand USD | -299028.571% |
| GH Research PLC | -315 Thousand USD | -53078.413% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -88530.688% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -31807.048% |
| Xencor, Inc. | -85.26 Million USD | -96.472% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -75705.174% |
| Replimune Group, Inc. | -2.65 Million USD | -6209.303% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -16630.521% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 194.19% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 86132.418% |
| Portage Biotech Inc. | -54 Thousand USD | -310107.407% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -177058.268% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -44332.891% |
| OncoCyte Corporation | 413 Thousand USD | 40659.806% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -3726529.588% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -75455755.856% |
| Purple Biotech Ltd. | -196 Thousand USD | -85365.306% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 1967.886% |
| scPharmaceuticals Inc. | 9.78 Million USD | 1812.451% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -1503.76% |
| HilleVax, Inc. | -2.15 Million USD | -7669.573% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -172592.784% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -1116348.947% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -24976.647% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -728213.043% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -2231560.396% |
| Savara Inc. | -44.26 Million USD | -278.456% |
| Curis, Inc. | 9.81 Million USD | 1807.39% |
| Daré Bioscience, Inc. | 2.76 Million USD | 6148.408% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -134137.266% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -9588.375% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -73370.175% |
| BeiGene, Ltd. | 2.07 Billion USD | 108.058% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -5891.344% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 58.087% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 395.498% |
| Erasca, Inc. | -3.73 Million USD | -4388.532% |
| bluebird bio, Inc. | -4.03 Million USD | -4056.625% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -593535.268% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 108.796% |
| DBV Technologies S.A. | 15.72 Million USD | 1165.056% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -593535.268% |
| Moderna, Inc. | 2.15 Billion USD | 107.773% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -18207.322% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 2192.331% |
| Molecular Templates, Inc. | 50.39 Million USD | 432.398% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -31152.239% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 225.207% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -2592.253% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -325.773% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | -50.738% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -4568.673% |
| MacroGenics, Inc. | 50.52 Million USD | 431.53% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -2646.999% |
| Prime Medicine, Inc. | -147.9 Million USD | -13.256% |
| Aditxt, Inc. | -111.66 Thousand USD | -149919.703% |
| Adagene Inc. | 18.11 Million USD | 1024.893% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 34426.23% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 219.479% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 206.13% |
| SciSparc Ltd. | 2.19 Million USD | 7728.051% |
| Vericel Corporation | 135.57 Million USD | 223.556% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -668637.275% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -540575.231% |
| Generation Bio Co. | -73.91 Million USD | -126.64% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -38232.265% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 406.692% |
| Invivyd, Inc. | -2.02 Million USD | -8159.961% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 44.319% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -161844.353% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 273.825% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 270.43% |
| ADMA Biologics, Inc. | 88.21 Million USD | 289.884% |
| Clene Inc. | 533 Thousand USD | 31528.143% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 794.806% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -17403.866% |
| GeoVax Labs, Inc. | -20.72 Million USD | -708.426% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 8526.157% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -86105.974% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 436.336% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -2261.985% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -19937.321% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 300.818% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 229216.971% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 415.097% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 3.277% |
| Trevena, Inc. | 1.45 Million USD | 11612.852% |
| Surrozen, Inc. | -27.23 Million USD | -515.174% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -47353.824% |
| Cingulate Inc. | -582.91 Thousand USD | -28636.803% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -540261.29% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -750.358% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -2212740.159% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -18913.848% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 124.609% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -16854.656% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -297212.839% |
| Kronos Bio, Inc. | 1.37 Million USD | 12309.329% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -212.138% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -57267.123% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -34204.157% |
| ImmunityBio, Inc. | -17.89 Million USD | -836.344% |
| Korro Bio, Inc. | -3.63 Million USD | -4514.656% |
| Kineta, Inc. | 5.43 Million USD | 3183.232% |
| BioVie Inc. | -229.37 Thousand USD | -72929.118% |
| Codexis, Inc. | 57.33 Million USD | 392.169% |
| Celularity Inc. | 6.75 Million USD | 2579.822% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 4274.234% |
| Celcuity Inc. | -142.77 Thousand USD | -117228.328% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 331216.822% |
| Cibus, Inc. | 1.42 Million USD | 11880.028% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -44689.305% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -630.887% |
| IN8bio, Inc. | -2.5 Million USD | -6597.801% |
| Kodiak Sciences Inc. | -25.94 Million USD | -545.593% |
| Annexon, Inc. | -3.26 Million USD | -5027.395% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -8095.303% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -301.351% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 26273.75% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 121.517% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 196.853% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -8716.421% |
| Arcellx, Inc. | 108.27 Million USD | 254.704% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -417.507% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 311.494% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -691.944% |
| Moolec Science SA | -143.3 Thousand USD | -116791.944% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -295.841% |
| Geron Corporation | -123.5 Million USD | -35.634% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 5196.197% |
| Royalty Pharma plc | 1.79 Billion USD | 109.338% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -138.996% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -4637552.27% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 72493.481% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | -50.351% |
| Humacyte, Inc. | -76.55 Million USD | -118.827% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -17548.187% |
| 89bio, Inc. | -273 Thousand USD | -61259.707% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -13226.333% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -19653.774% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -136088.618% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 15069.794% |
| Notable Labs, Ltd. | 113 Thousand USD | 148340.708% |
| Liquidia Corporation | 14.6 Million USD | 1247.342% |
| Mustang Bio, Inc. | -2.22 Million USD | -7428.629% |
| Immunovant, Inc. | -231 Thousand USD | -72416.017% |
| Quantum-Si incorporated | 488 Thousand USD | 34426.23% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -201.503% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -558273.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 9096.348% |
| Acasti Pharma Inc. | -11 Thousand USD | -1522736.364% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -81766.121% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -25732.519% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 14864.23% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -43866.404% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -8455.26% |
| PepGen Inc. | -1.18 Million USD | -14047.973% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -131799.213% |
| United Therapeutics Corporation | 2.07 Billion USD | 108.092% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -631.589% |
| Solid Biosciences Inc. | -76.56 Million USD | -118.79% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -202740.778% |
| Immuneering Corporation | -764.13 Thousand USD | -21821.695% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 252894.881% |
| Belite Bio, Inc | -399 Thousand USD | -41882.957% |
| XOMA Corporation | 3.86 Million USD | 4438.565% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -736.055% |
| Bionomics Limited | -434.44 Thousand USD | -38457.345% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -15497.02% |
| uniQure N.V. | 2.21 Million USD | 7662.619% |
| Cassava Sciences, Inc. | -89.42 Million USD | -87.325% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | -81.942% |
| Forte Biosciences, Inc. | -9000.00 USD | -1861144.444% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -19961.317% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -38232.265% |
| Altimmune, Inc. | -65.37 Million USD | -156.24% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 146.27% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -15497.02% |
| Compugen Ltd. | 31.45 Million USD | 632.545% |
| Peak Bio, Inc. | 367.76 Thousand USD | 45648.157% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 783.276% |
| Benitec Biopharma Inc. | 108 Thousand USD | 155203.704% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -214658.974% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -13824.522% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -9093.853% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -140666.387% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -13824.522% |
| Instil Bio, Inc. | -4.75 Million USD | -3422.119% |
| argenx SE | 1.1 Billion USD | 115.112% |
| Immunome, Inc. | -8.9 Million USD | -1780.678% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -8763.069% |
| Verona Pharma plc | -679.62 Thousand USD | -24547.746% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -95621.143% |
| Shattuck Labs, Inc. | -2.38 Million USD | -6923.564% |
| CervoMed Inc. | -1.29 Million USD | -12849.019% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -6859.369% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -3406.636% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 6879.118% |
| Moolec Science SA | -143.3 Thousand USD | -116791.944% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -40953.844% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -6170.269% |
| AnaptysBio, Inc. | 14.78 Million USD | 1233.293% |
| Design Therapeutics, Inc. | -537 Thousand USD | -31094.041% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -39129.977% |
| NeurAxis, Inc. | 2.15 Million USD | 7867.037% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 7905.778% |
| Lumos Pharma, Inc. | 2 Million USD | 8446.388% |
| Achilles Therapeutics plc | -4.73 Million USD | -3440.532% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -95621.143% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -158416.205% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 629.117% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 19530.58% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -16131.783% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -267.77% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 389662.791% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -20278.589% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -1272981.015% |
| Palisade Bio, Inc. | 246 Thousand USD | 68194.309% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -507512.121% |
| Beam Therapeutics Inc. | -59.67 Million USD | -180.721% |
| Neurogene Inc. | -3.26 Million USD | -5035.254% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 220.222% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -4437.161% |
| Sesen Bio, Inc. | 40 Million USD | 518.78% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -56301.347% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -4059.684% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -1651.119% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 1289.716% |
| Athira Pharma, Inc. | -969 Thousand USD | -17187.1% |
| Vaccinex, Inc. | -16 Million USD | -946.688% |
| HCW Biologics Inc. | -574.82 Thousand USD | -29041.442% |
| XOMA Corporation | 3.86 Million USD | 4438.565% |
| Nektar Therapeutics | 53.47 Million USD | 413.235% |
| Arvinas, Inc. | 71.8 Million USD | 333.304% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | -100.707% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -166.845% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -51922.36% |
| Rezolute, Inc. | -36 Thousand USD | -465211.111% |
| Clene Inc. | 533 Thousand USD | 31528.143% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -13046005.919% |
| BeyondSpring Inc. | 1.75 Million USD | 9666.648% |
| Synlogic, Inc. | -1.92 Million USD | -8606.445% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -452635.135% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -2545.483% |
| Peak Bio, Inc. | 367.76 Thousand USD | 45648.157% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -783.362% |
| Krystal Biotech, Inc. | 47.6 Million USD | 451.879% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 218.726% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 3433.572% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -6369.596% |
| MannKind Corporation | 136.19 Million USD | 222.998% |
| Ikena Oncology, Inc. | -50.49 Million USD | -231.759% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 253.943% |
| Gossamer Bio, Inc. | -4.38 Million USD | -3720.114% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -66373.016% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -3350140.0% |
| Legend Biotech Corporation | 140.92 Million USD | 218.863% |
| Mural Oncology plc | -2.56 Million USD | -6425.594% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -30301.452% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -167412.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 907.131% |
| REGENXBIO Inc. | 53.02 Million USD | 415.888% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -3027.001% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -86975.763% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -9571.594% |
| Vaxart, Inc. | -60.76 Million USD | -175.681% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -63646.099% |
| Cellectis S.A. | 18 Thousand USD | 930722.222% |
| Longeveron Inc. | 221 Thousand USD | 75897.285% |
| Repare Therapeutics Inc. | -80.07 Million USD | -109.207% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 115.326% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -12845.286% |
| Revolution Medicines, Inc. | -399.66 Million USD | 58.087% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -478505.714% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 341961.224% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 101.946% |
| Denali Therapeutics Inc. | -93.34 Million USD | -79.455% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -668637.275% |
| Veru Inc. | 7.56 Million USD | 2314.031% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -110835.099% |
| Cingulate Inc. | -582.91 Thousand USD | -28636.803% |
| Passage Bio, Inc. | -3.72 Million USD | -4401.801% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -1390733.61% |
| Exicure, Inc. | -1.42 Million USD | -11671.75% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -43636.815% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 6297.262% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -32574.111% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 345.886% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -111868.023% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -182.931% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 42941.944% |
| OmniAb, Inc. | 14.66 Million USD | 1242.101% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 937.853% |
| Lipocine Inc. | -2.85 Million USD | -5775.928% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -8989.094% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -2836.231% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -11020.826% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 322.412% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -257610.769% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 298.719% |
| Ocugen, Inc. | -33.53 Million USD | -399.484% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -5197.66% |
| Q32 Bio Inc. | 578 Thousand USD | 29081.315% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -63112.075% |
| Alumis Inc. Common Stock | -1.28 Million USD | -12946.106% |
| Equillium, Inc. | 35.95 Million USD | 565.855% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -9713.24% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 33556.965% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -4051956.12% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -64576.448% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 39727.926% |
| Dominari Holdings Inc. | 2.03 Million USD | 8315.4% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -91201.623% |
| vTv Therapeutics Inc. | -13.59 Million USD | -1132.159% |
| Bio-Techne Corporation | 773.07 Million USD | 121.668% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 1067.215% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 136.354% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -14229.512% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -598.549% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 1532.094% |
| Nkarta, Inc. | -5.86 Million USD | -2754.183% |
| BioCardia, Inc. | -7.24 Million USD | -2210.829% |
| Iterum Therapeutics plc | -1.75 Million USD | -9472.114% |